StonvexLoading…
StonvexStonvexStonvexCore line items from ONL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $147.65M | $164.86M | $195.04M | $208.12M |
Operating Income | $-139.03M | $-102.76M | $-56.85M | $-97.26M |
Net Income | $-139.31M | $-103.01M | $-57.30M | $-97.49M |
EPS (Diluted) | $-2.48 | $-1.84 | $-1.02 | $-1.72 |
Total Assets | $1.17B | $1.34B | $1.42B | $1.57B |
Total Liabilities | $545.99M | $571.17M | $536.93M | $595.22M |
Cash & Equivalents | $22.36M | $15.60M | $22.47M | $20.64M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 56.31M | 55.95M | 55.78M | 56.64M |